← Every company
Immunitybio Inc SEC Filings
What Immunitybio Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
IBRX overview →Filings on file
104
since Nov 10, 2016
Warning signs
1
latest Mar 19, 2025
Last results
Aug 4, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 4, 2026 | Results announced 8-K | Read ↗ |
| May 7, 2026 | Results announced 8-K | Read ↗ |
| Apr 9, 2026 | Results announced 8-K | Read ↗ |
| Feb 23, 2026 | Results announced 8-K | Read ↗ |
| Jan 15, 2026 | Results announced 8-K | Read ↗ |
| Nov 5, 2025 | Results announced 8-K | Read ↗ |
| Aug 5, 2025 | Results announced 8-K | Read ↗ |
| Jul 25, 2025 | Results announcedMaterial agreement 8-K | Read ↗ |
| May 12, 2025 | Results announced 8-K | Read ↗ |
| Apr 15, 2025 | Results announced 8-K | Read ↗ |
| Mar 3, 2025 | Results announced 8-K | Read ↗ |
| Nov 12, 2024 | Results announced 8-K | Read ↗ |
| Feb 14, 2023 | Results announced 8-K | Read ↗ |
| Dec 12, 2022 | Results announcedMaterial agreementNew debt 8-K | Read ↗ |
| Sep 13, 2021 | Results announced 8-K | Read ↗ |
| Jun 11, 2021 | Results announcedShareholder vote 8-K | Read ↗ |
| May 3, 2021 | Results announcedMaterial agreement 8-K | Read ↗ |
Source: Immunitybio Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on IBRX
Company overviewEverything on IBRX in one place, with the price.Insider tradingWhat IBRX's own officers and directors buy and sell.Planned salesSales IBRX insiders have filed notice of.Executive payWhat IBRX awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in IBRX.Funds holding itWhich funds and ETFs hold IBRX, and how big a bet.LobbyingWhat IBRX spends lobbying Congress, and on what.PatentsWhat IBRX is filing at the patent office.